124 related articles for article (PubMed ID: 28989037)
1. Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy.
Shukuya T; Patel S; Shane-Carson K; He K; Bertino EM; Shilo K; Otterson GA; Carbone DP
J Thorac Oncol; 2018 Feb; 13(2):e17-e19. PubMed ID: 28989037
[No Abstract] [Full Text] [Related]
2. Germline mutations in lung cancer.
Shukuya T; Takahashi K
Respir Investig; 2019 May; 57(3):201-206. PubMed ID: 30639082
[TBL] [Abstract][Full Text] [Related]
3. Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx.
Clery E; Pisapia P; Migliatico I; Pepe F; De Luca C; Russo M; De Rosa F; Smeraglia F; Insabato L; Vigliar E; Malapelle U; Mariconda M; Gridelli C; Troncone G
Diagn Cytopathol; 2020 Aug; 48(8):759-764. PubMed ID: 32320137
[TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
5. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
Bennett CW; Berchem G; Kim YJ; El-Khoury V
Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.
Guo Q; Wang J; Xiao J; Wang L; Hu X; Yu W; Song G; Lou J; Chen J
Mol Cancer; 2018 Aug; 17(1):131. PubMed ID: 30153823
[TBL] [Abstract][Full Text] [Related]
8. Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.
Rachiglio AM; Esposito Abate R; Sacco A; Pasquale R; Fenizia F; Lambiase M; Morabito A; Montanino A; Rocco G; Romano C; Nappi A; Iaffaioli RV; Tatangelo F; Botti G; Ciardiello F; Maiello MR; De Luca A; Normanno N
Oncotarget; 2016 Oct; 7(41):66595-66605. PubMed ID: 27448974
[TBL] [Abstract][Full Text] [Related]
9. Detection of Discrepant Driver Mutations in a Patient with Two Synchronous Primary Non-Small Cell Lung Cancers (NSCLCs) with Liquid Biopsy.
Lakis S; Heukamp LC; Griesinger F
J Thorac Oncol; 2017 Nov; 12(11):e186-e188. PubMed ID: 29074212
[No Abstract] [Full Text] [Related]
10. Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer.
Cui S; Zhang W; Xiong L; Pan F; Niu Y; Chu T; Wang H; Zhao Y; Jiang L
Oncotarget; 2017 Jan; 8(2):2771-2780. PubMed ID: 27926526
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Sequencing from Liquid Biopsies in Lung Cancer Patients: Advances in Comprehensive Biomarker Testing.
Sholl LM
J Thorac Oncol; 2017 Oct; 12(10):1464-1466. PubMed ID: 28939146
[No Abstract] [Full Text] [Related]
12. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
Renieri A; Mencarelli MA; Cetta F; Baldassarri M; Mari F; Furini S; Piu P; Ariani F; Dragani TA; Frullanti E
Lung Cancer; 2014 Aug; 85(2):168-74. PubMed ID: 24954872
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.
Braig F; Voigtlaender M; Schieferdecker A; Busch CJ; Laban S; Grob T; Kriegs M; Knecht R; Bokemeyer C; Binder M
Oncotarget; 2016 Jul; 7(28):42988-42995. PubMed ID: 27119512
[TBL] [Abstract][Full Text] [Related]
14. Omic Approach in Non-smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine.
Baldassarri M; Fallerini C; Cetta F; Ghisalberti M; Bellan C; Furini S; Spiga O; Crispino S; Gotti G; Ariani F; Paladini P; Renieri A; Frullanti E
Cancer Res Treat; 2018 Apr; 50(2):356-365. PubMed ID: 28546520
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of Germline
Hu Y; Alden RS; Odegaard JI; Fairclough SR; Chen R; Heng J; Feeney N; Nagy RJ; Shah J; Ulrich B; Gutierrez M; Lanman RB; Garber JE; Paweletz CP; Oxnard GR
Clin Cancer Res; 2017 Dec; 23(23):7351-7359. PubMed ID: 28947568
[No Abstract] [Full Text] [Related]
16. Next Generation Sequencing Uncovers Potential Genetic Driver Mutations of Malignant Pulmonary Granular Cell Tumor.
Xu S; Zhao Q; Wei S; Wu Y; Liu J; Shi T; Zhou Q; Chen J
J Thorac Oncol; 2015 Oct; 10(10):e106-9. PubMed ID: 26398830
[No Abstract] [Full Text] [Related]
17. Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.
Gale D; Lawson ARJ; Howarth K; Madi M; Durham B; Smalley S; Calaway J; Blais S; Jones G; Clark J; Dimitrov P; Pugh M; Woodhouse S; Epstein M; Fernandez-Gonzalez A; Whale AS; Huggett JF; Foy CA; Jones GM; Raveh-Amit H; Schmitt K; Devonshire A; Green E; Forshew T; Plagnol V; Rosenfeld N
PLoS One; 2018; 13(3):e0194630. PubMed ID: 29547634
[TBL] [Abstract][Full Text] [Related]
18. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
[TBL] [Abstract][Full Text] [Related]
19. [Progress of liquid biopsy technique and clinical application in lung cancer].
Wang NF; Yang Y; Chen SF
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):881-883. PubMed ID: 30423633
[No Abstract] [Full Text] [Related]
20. Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing.
Franceschi S; Lessi F; Aretini P; Mazzanti CM; Menicagli M; La Ferla M; De Gregorio V; Caramella D; Naccarato AG; Bevilacqua G; Bonadio AG; Pasqualetti F
Neuro Oncol; 2016 Feb; 18(2):298-300. PubMed ID: 26803811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
